Murdoch Children's Research Institute
Logo
  • Home
  • About
    About Participating sites Consortium members Collaborative Partners Translation Partners
  • Code of ethics
  • Projects
  • Resources
    Resources News Publications
  • Contact

Advancing the evidence base for off-label medications in children

A multicentre prospective audit with an embedded pharmacokinetic and pharmacodynamic study to determine the dosing regimens, safety and efficacy of off-label medications used in children.

« Previous project
ID-MAGIC: Individualised Dose optiMisAtion of Ganciclovir in Immunocompromised Children Trial
Next project »
Audit of therapeutic drug monitoring of Vancomycin in paediatric tertiary hospitals
  • Projects
  • BEST Trial: Bone and Joint infection – Simplifying treatment in Children Trial
  • FosUTI Trial: Optimising the treatment of antibiotic resistant urinary tract infections in children
  • O-SNAP: Optimizing antibiotic dosing in the Staphylococcus aureus Network Adaptive Platform trial
  • ID-MAGIC: Individualised Dose optiMisAtion of Ganciclovir in Immunocompromised Children Trial
  • Advancing the evidence base for off-label medications in children
  • Audit of therapeutic drug monitoring of Vancomycin in paediatric tertiary hospitals
  • A pharmacokinetic study of fluoroquinolones using capillary microsampling
  • Future directions – scoping literature review for antimicrobials for drug-resistant bacterial infections in children
Murdoch Children's Research Institute

Ⓒ 2023 Murdoch Children's Research Institute

  • We follow the Australian Privacy Principles
  • General Privacy Policy
  • Terms & Conditions